Literature DB >> 2496036

Protection of mice against Listeria monocytogenes infection by recombinant human tumor necrosis factor alpha.

J V Desiderio1, P A Kiener, P F Lin, G A Warr.   

Abstract

Recombinant human tumor necrosis factor alpha (rHuTNF-alpha) administered intravenously to mice resulted in enhanced resistance to a lethal challenge infection of Listeria monocytogenes given 24 h later. The observed protection was lost following treatment of the rHuTNF-alpha preparations with rabbit polyclonal antibody rHuTNF-alpha but not with normal rabbit immunoglobulin G.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2496036      PMCID： PMC313322          DOI： 10.1128/iai.57.5.1615-1617.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  21 in total

1.  Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor.

Authors:  R L Berkow; D Wang; J W Larrick; R W Dodson; T H Howard
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

2.  Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.

Authors:  R Philip; L B Epstein
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

Review 3.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

Review 4.  Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury.

Authors:  H Z Movat
Journal:  J Lab Clin Med       Date:  1987-12

5.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

7.  Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.

Authors:  D F Jelinek; P E Lipsky
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

8.  Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes.

Authors:  T R Ulich; J del Castillo; M Keys; G A Granger; R X Ni
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

9.  Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.

Authors:  S N Vogel; E N Kaufman; M D Tate; R Neta
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

10.  Pharmacokinetics of murine tumor necrosis factor.

Authors:  D A Flick; G E Gifford
Journal:  J Immunopharmacol       Date:  1986
View more
  12 in total

1.  Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo.

Authors:  D R Roach; H Briscoe; K Baumgart; D A Rathjen; W J Britton
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 2.  Use of immune modulators in nonspecific therapy of bacterial infections.

Authors:  M T Vogels; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies.

Authors:  D A Leiby; A H Fortier; R M Crawford; R D Schreiber; C A Nacy
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

4.  Role of tumor necrosis factor in Listeria resistance of nude mice.

Authors:  T Hauser; K Frei; R M Zinkernagel; T P Leist
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

5.  A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion.

Authors:  W J Britton; N Meadows; D A Rathjen; D R Roach; H Briscoe
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  Restricted replication of Listeria monocytogenes in a gamma interferon-activated murine hepatocyte line.

Authors:  G Szalay; J Hess; S H Kaufmann
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

7.  Use of recombinant interleukin-2 to enhance adoptive transfer of resistance to Listeria monocytogenes infection.

Authors:  M Haak-Frendscho; C J Czuprynski
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.

Authors:  L E Bermudez; M Wu; M Petrofsky; L S Young
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Inhibition of infection of macrophages with Ehrlichia risticii by cytochalasins, monodansylcadaverine, and taxol.

Authors:  Y Rikihisa; Y Zhang; J Park
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.